Literature DB >> 15580334

Levosimendan in septic cardiac failure.

A Noto, M Giacomini, A Palandi, L Stabile, C Reali-Forster, G Iapichino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15580334     DOI： 10.1007/s00134-004-2502-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  3 in total

1.  Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock.

Authors:  A Oldner; D Konrad; E Weitzberg; A Rudehill; P Rossi; M Wanecek
Journal:  Crit Care Med       Date:  2001-11       Impact factor: 7.598

2.  The calcium sensitizer levosimendan attenuates endotoxin-evoked myocardial dysfunction in isolated guinea pig hearts.

Authors:  Matthias Behrends; Jürgen Peters
Journal:  Intensive Care Med       Date:  2003-07-17       Impact factor: 17.440

3.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.

Authors:  R Phillip Dellinger; Jean M Carlet; Henry Masur; Herwig Gerlach; Thierry Calandra; Jonathan Cohen; Juan Gea-Banacloche; Didier Keh; John C Marshall; Margaret M Parker; Graham Ramsay; Janice L Zimmerman; Jean-Louis Vincent; M M Levy
Journal:  Intensive Care Med       Date:  2004-03-03       Impact factor: 17.440
  3 in total
  9 in total

1.  Levosimendan in septic shock: another piece in the puzzle, but many pieces are still lacking.

Authors:  Daniel De Backer; Fabio Silvio Taccone; Peter Radermacher
Journal:  Intensive Care Med       Date:  2007-01-30       Impact factor: 17.440

Review 2.  [Role of Levosimendan in intensive care treatment of myocardial insufficiency].

Authors:  S Rehberg; C Ertmer; H Van Aken; M Lange; K Bröking; A Morelli; M Westphal
Journal:  Anaesthesist       Date:  2007-01       Impact factor: 1.041

Review 3.  Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both?

Authors:  Konstantinos Drosatos; Anastasios Lymperopoulos; Peter Johannes Kennel; Nina Pollak; P Christian Schulze; Ira J Goldberg
Journal:  Curr Heart Fail Rep       Date:  2015-04

Review 4.  Recent advances in sepsis and septic shock.

Authors:  Praveen Khilnani; Satish Deopujari; Joe Carcillo
Journal:  Indian J Pediatr       Date:  2008-09-04       Impact factor: 1.967

5.  Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine.

Authors:  Joe Brierley; Joseph A Carcillo; Karen Choong; Tim Cornell; Allan Decaen; Andreas Deymann; Allan Doctor; Alan Davis; John Duff; Marc-Andre Dugas; Alan Duncan; Barry Evans; Jonathan Feldman; Kathryn Felmet; Gene Fisher; Lorry Frankel; Howard Jeffries; Bruce Greenwald; Juan Gutierrez; Mark Hall; Yong Y Han; James Hanson; Jan Hazelzet; Lynn Hernan; Jane Kiff; Niranjan Kissoon; Alexander Kon; Jose Irazuzta; Jose Irazusta; John Lin; Angie Lorts; Michelle Mariscalco; Renuka Mehta; Simon Nadel; Trung Nguyen; Carol Nicholson; Mark Peters; Regina Okhuysen-Cawley; Tom Poulton; Monica Relves; Agustin Rodriguez; Ranna Rozenfeld; Eduardo Schnitzler; Tom Shanley; Saraswati Kache; Sara Skache; Peter Skippen; Adalberto Torres; Bettina von Dessauer; Jacki Weingarten; Timothy Yeh; Arno Zaritsky; Bonnie Stojadinovic; Jerry Zimmerman; Aaron Zuckerberg
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

6.  Levosimendan for resuscitating the microcirculation in patients with septic shock: a randomized controlled study.

Authors:  Andrea Morelli; Abele Donati; Christian Ertmer; Sebastian Rehberg; Matthias Lange; Alessandra Orecchioni; Valeria Cecchini; Giovanni Landoni; Paolo Pelaia; Paolo Pietropaoli; Hugo Van Aken; Jean-Louis Teboul; Can Ince; Martin Westphal
Journal:  Crit Care       Date:  2010-12-23       Impact factor: 9.097

Review 7.  Sepsis-induced cardiomyopathy.

Authors:  Francisco J Romero-Bermejo; Manuel Ruiz-Bailen; Julian Gil-Cebrian; Maria J Huertos-Ranchal
Journal:  Curr Cardiol Rev       Date:  2011-08

8.  Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: a prospective observational study.

Authors:  Julia Hasslacher; Klaudija Bijuklic; Cristina Bertocchi; Jordan Kountchev; Romuald Bellmann; Stefan Dunzendorfer; Michael Joannidis
Journal:  Crit Care       Date:  2011-07-12       Impact factor: 9.097

9.  An efficacy and mechanism evaluation study of Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis (LeoPARDS): protocol for a randomized controlled trial.

Authors:  Robert M L'E Orme; Gavin D Perkins; Daniel F McAuley; Kathleen D Liu; Alexina J Mason; Andrea Morelli; Mervyn Singer; Deborah Ashby; Anthony C Gordon
Journal:  Trials       Date:  2014-06-02       Impact factor: 2.279
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.